Consensus Cellebrite DI Ltd.

Equities

CLBT

IL0011794802

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
10.88 ^USD	+1.59%		+3.92%	+25.64%

04-19	Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target	MT
04-01	BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating	MT

Evolution of the average Target Price on Cellebrite DI Ltd.

Price target over the last 5 years

History of analyst recommendation changes

4f18195372aa66d3dbaaf.9EqSO48zgjPGfU-tPuHceh_K9M_lbBD1Jy4aWL75hLI.hR_8ZLxZ0H71LiXsUYmLQ0Croq6iPCa-F14sFtu24OOZIeVN6nfhX6tFGg~d102d13058af8632c3b5680bf907c71c

Analyst Recommendations on Cellebrite DI Ltd.

Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target	04-19	MT
BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating	04-01	MT
Needham Adjusts Price Target on Cellebrite to $13.50 From $13, Keeps Buy Rating	03-28	MT
William Blair Upgrades Cellebrite DI to Outperform From Market Perform	03-13	MT
BofA Securities Upgrades Cellebrite to Buy From Neutral on Solid Q4 Earnings, Business Momentum, Raises PT to $12 From $9	02-16	MT
Deutsche Bank Raises Cellebrite DI Price Target to $13 From $10, Maintains Buy Rating	02-16	MT
Deutsche Bank Adjusts Cellebrite DI Price Target to $9 From $6.50, Maintains Buy Rating	09/08/23	MT
Needham Adjusts Price Target on Cellebrite DI to $10 From $7, Keeps Buy Rating	09/08/23	MT
Craig-Hallum Starts Cellebrite DI at Buy With $11 Price Target	19/07/23	MT
Needham Adjusts Cellebrite DI Price Target to $7 From $6.50, Maintains Buy Rating	14/03/23	MT
Deutsche Bank Adjusts Cellebrite DI Price Target to $6.50 From $6, Maintains Buy Rating	16/02/23	MT
Deutsche Bank Adjusts Cellebrite DI's Price Target to $6 From $7, Maintains Buy Rating	17/01/23	MT
BofA Securities Downgrades Cellebrite DI to Neutral	12/08/22	MT
Deutsche Bank Adjusts Cellebrite's Price Target to $7 From $10, Maintains Buy Rating	12/08/22	MT
Cowen Adjusts Price Target on Cellebrite DI to $10 From $13, Keeps Outperform Rating	12/08/22	MT
William Blair Downgrades Cellebrite DI to Market Perform From Outperform	12/08/22	MT
Needham Adjusts Cellebrite DI's Price Target to $6 from $9.50, Keeps Buy Rating	13/05/22	MT
JPMorgan Starts Cellebrite DI at Overweight With $10.50 Price Target	24/02/22	MT
Deutsche Bank Adjusts Cellebrite DI's Price Target to $11 From $10.50, Maintains Buy Rating	17/02/22	MT
Deutsche Bank Initiates Coverage on Cellebrite DI With Buy Rating, $10.50 Price Target	11/02/22	MT
Needham Adjusts Price Target on Cellebrite DI to $9.50 From $12, Reiterates Buy Rating	29/12/21	MT
BofA Securities Starts Cellebrite DI at Buy with $11 Price Target	02/12/21	MT
CELLEBRITE DI : Citigroup Starts Cellebrite at Buy with $15 Price Target	21/10/21	MT
CELLEBRITE DI : Needham & Co Starts Cellebrite at Buy with $12 Price Target	29/09/21	MT
CELLEBRITE DI : William Blair Initiates Cellebrite at Outperform Rating	24/09/21	MT